Bacaro, Alejandro D.
HRN: 24-48-47 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/10/2024
CEFTRIAXONE 1G (VIAL)
02/10/2024
02/16/2024
2G
2g
Q24hours
CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes